FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2082662386> ?p ?o ?g. }

• W2082662386 endingPage "361" @default.
• W2082662386 startingPage "352" @default.
• W2082662386 abstract "Abstract BACKGROUND. Many liver staging systems have been proposed for patients with hepatocellular carcinoma after locoregional therapy; however, controversies persist regarding which system is the best. In this study, the authors compared the performance of 7 staging systems in a cohort of patients with hepatocellular carcinoma who underwent transarterial chemoembolization. METHODS. In total, 131 patients with hepatocellular carcinoma who underwent transarterial chemoembolization between August 1998 and February 2005 were included in the study. Demographic, laboratory, and tumor characteristics were determined at diagnosis and before therapy. At the time of censorship, 109 patients had died (83.2%). Predictors of survival were identified by using the Cox proportional hazards model. The likelihood‐ratio chi‐square statistic and the Akaike Information Criterion were calculated for 7 prognostic systems to evaluate their discriminatory ability. Comparisons of the survival rate between each stage were performed to evaluate the monotonicity of the gradients using Kaplan‐Meier estimation and the log‐rank test. RESULTS. The 5‐year survival rate for the entire cohort was 13.6%. The independent predictors of survival were serum albumin level (≤3.4 g/dL), the presence of ascites, serum α‐fetoprotein level (>60 ng/mL), and portal or hepatic vein tumor thrombosis ( P = .001, P = .001, P = .004, and P = .000, respectively). The Cancer of the Liver Italian Program classification system was superior to the other 6 prognostic systems regarding discriminatory ability and the monotonicity of the gradients. CONCLUSIONS. In this comparison of many staging systems, the Cancer of Liver Italian Program system provided the best prognostic stratification for a cohort the patients with hepatocellular carcinoma who underwent transarterial chemoembolization. Cancer 2008. © 2007 American Cancer Society." @default.
• W2082662386 created "2016-06-24" @default.
• W2082662386 creator A5038164576 @default.
• W2082662386 creator A5047156899 @default.
• W2082662386 creator A5063886936 @default.
• W2082662386 creator A5074393064 @default.
• W2082662386 creator A5076677012 @default.
• W2082662386 creator A5078651921 @default.
• W2082662386 creator A5080614973 @default.
• W2082662386 creator A5084647113 @default.
• W2082662386 date "2007-11-15" @default.
• W2082662386 modified "2023-10-12" @default.
• W2082662386 title "Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization" @default.
• W2082662386 cites W1562772349 @default.
• W2082662386 cites W1681392131 @default.
• W2082662386 cites W1969368041 @default.
• W2082662386 cites W1970111319 @default.
• W2082662386 cites W1971693026 @default.
• W2082662386 cites W1993128964 @default.
• W2082662386 cites W2001928308 @default.
• W2082662386 cites W2008206360 @default.
• W2082662386 cites W2010680051 @default.
• W2082662386 cites W2020215421 @default.
• W2082662386 cites W2028612069 @default.
• W2082662386 cites W2036277928 @default.
• W2082662386 cites W2038814919 @default.
• W2082662386 cites W2048297291 @default.
• W2082662386 cites W2058786880 @default.
• W2082662386 cites W2059043558 @default.
• W2082662386 cites W2066998654 @default.
• W2082662386 cites W2068077883 @default.
• W2082662386 cites W2084139018 @default.
• W2082662386 cites W2088736811 @default.
• W2082662386 cites W2089114108 @default.
• W2082662386 cites W2090293099 @default.
• W2082662386 cites W2093302911 @default.
• W2082662386 cites W2108346479 @default.
• W2082662386 cites W2131357269 @default.
• W2082662386 cites W2140632878 @default.
• W2082662386 cites W2142635246 @default.
• W2082662386 cites W2147172608 @default.
• W2082662386 cites W2162322495 @default.
• W2082662386 cites W2591170673 @default.
• W2082662386 cites W2595391283 @default.
• W2082662386 cites W4253752771 @default.
• W2082662386 doi "https://doi.org/10.1002/cncr.23185" @default.
• W2082662386 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18465802" @default.
• W2082662386 hasPublicationYear "2007" @default.
• W2082662386 type Work @default.
• W2082662386 sameAs 2082662386 @default.
• W2082662386 citedByCount "108" @default.
• W2082662386 countsByYear W20826623862012 @default.
• W2082662386 countsByYear W20826623862013 @default.
• W2082662386 countsByYear W20826623862014 @default.
• W2082662386 countsByYear W20826623862015 @default.
• W2082662386 countsByYear W20826623862016 @default.
• W2082662386 countsByYear W20826623862017 @default.
• W2082662386 countsByYear W20826623862018 @default.
• W2082662386 countsByYear W20826623862019 @default.
• W2082662386 countsByYear W20826623862020 @default.
• W2082662386 countsByYear W20826623862021 @default.
• W2082662386 countsByYear W20826623862022 @default.
• W2082662386 countsByYear W20826623862023 @default.
• W2082662386 crossrefType "journal-article" @default.
• W2082662386 hasAuthorship W2082662386A5038164576 @default.
• W2082662386 hasAuthorship W2082662386A5047156899 @default.
• W2082662386 hasAuthorship W2082662386A5063886936 @default.
• W2082662386 hasAuthorship W2082662386A5074393064 @default.
• W2082662386 hasAuthorship W2082662386A5076677012 @default.
• W2082662386 hasAuthorship W2082662386A5078651921 @default.
• W2082662386 hasAuthorship W2082662386A5080614973 @default.
• W2082662386 hasAuthorship W2082662386A5084647113 @default.
• W2082662386 hasConcept C126322002 @default.
• W2082662386 hasConcept C141071460 @default.
• W2082662386 hasConcept C143998085 @default.
• W2082662386 hasConcept C146357865 @default.
• W2082662386 hasConcept C151730666 @default.
• W2082662386 hasConcept C2776231280 @default.
• W2082662386 hasConcept C2776283816 @default.
• W2082662386 hasConcept C2777546739 @default.
• W2082662386 hasConcept C2778019345 @default.
• W2082662386 hasConcept C2780496750 @default.
• W2082662386 hasConcept C50382708 @default.
• W2082662386 hasConcept C71924100 @default.
• W2082662386 hasConcept C72563966 @default.
• W2082662386 hasConcept C86803240 @default.
• W2082662386 hasConcept C90924648 @default.
• W2082662386 hasConceptScore W2082662386C126322002 @default.
• W2082662386 hasConceptScore W2082662386C141071460 @default.
• W2082662386 hasConceptScore W2082662386C143998085 @default.
• W2082662386 hasConceptScore W2082662386C146357865 @default.
• W2082662386 hasConceptScore W2082662386C151730666 @default.
• W2082662386 hasConceptScore W2082662386C2776231280 @default.
• W2082662386 hasConceptScore W2082662386C2776283816 @default.
• W2082662386 hasConceptScore W2082662386C2777546739 @default.
• W2082662386 hasConceptScore W2082662386C2778019345 @default.
• W2082662386 hasConceptScore W2082662386C2780496750 @default.
• W2082662386 hasConceptScore W2082662386C50382708 @default.

• next